Evaluation of HER-2 neu oncoprotein expression as a prognostic indicator of local recurrence in conservatively treated breast cancer: A case-control study

International Journal of Radiation Oncology Biology Physics

Volumn 35, Issue 4, 1996, Pages 751-757

  Haffty, Bruce G ^a   Brown, Felix ^a   Carter, Darryl ^a   Flynn, Stuart ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Conservative surgery; HER 2 neu; Local recurrence; Radiation therapy

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RADIOTHERAPY; CANCER RECURRENCE; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MASTECTOMY; ONCOGENE NEU; PRIORITY JOURNAL;

EID: 0030200381     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/0360-3016(96)00150-2     Document Type: Article

References (25)

1. 1. Allred, D.; Clark, G.; Tandon, A.; Molina, R.; Tormey, D.; Osborne, C.; Gilchrist, K.; Mansour, E.; Abeloff, M.; Eudey, L.; McGuire, W. Her-2/neu in node-negative breast cancer: Prognostic significance of overexpression influenced by the presence of in situ carcinoma. J. Clin. Oncol. 10:599-605; 1992.
2. 2. Borg, A.; Tandon, A.; Sigurdsson, H.; Clark, G.; Ferno, M.; Fuqua, S.; Killander, D.; McGuire, W. Her-2/neu amplification predicts poor survival in node-positive breast cancer. Cancer Res. 50:4332-4337; 1990.
3. 3. Clark, G.; McGuire, W. Follow-up study of Her-2/neu amplification in primary breast cancer. Cancer Res. 51:944-948; 1991.
4. 4. Cohen, P.; Zakris, E.; Shih, L.-S.; Connolly. J.; Harris, J.; Schnitt, S. HER2/neu oncogene expression in invasive breast cancers with and without an extensive intraductal component (Abstr). Lab. Invest. 68:14A; 1993.
5. 5. Fisher, B.; Anderson, S.; Fisher, E.; Redmond, C.; Wickerham, D. L.; Wolmark, N.; Mamounas, E. P.; Deutsch, M.; Margolese, R. Significance of ipsilateral breast tumour recurrence after lumpectomy. Lancet 338:327-331; 1991.
6. 6. Fisher, B.; Redmond, C.; Poisson, R.; Margolese, R.; Wolmark, N.; Wickerham, W.; Fischer, E.; Deutsch, M.; Caplan, R.; Pilch, Y.; Glass, A.; Shibata, H.; Lerner, H.; Terz, J.; Sidorovich, L. Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. N. Engl. J. Med. 320:822-828; 1989.
7. 7. Fowble, B.; Rubenstein, J.; Solin, L. J.; Schultz, D. J.; Goodman, R. L. Breast recurrences following conservative surgery and radiation: Patterns of failure, prognosis and pathologic findings from mastectomy specimens with implications for treatment. Int. J. Radiat. Oncol. Biol. Phys. 19:833-842; 1990.
8. 8. Fowble, B. L.; Solin, L. J.; Schultz, D. J.; Goodman, R. L. Ten year results of conservative surgery and irradiation for stage I and II breast cancer. Int. J. Radiat. Oncol. Biol. Phys. 21:269-277; 1991.
9. 9. Gullick, W.; Love, S.; Wright, C.; Barnes, D.; Gusterson, B.; Harris, A.; Altman, D. c-erb B-2 protein overexpression in breast cancer is a risk factor in patients with involved and uninvolved lymph nodes. Br. J. Cancer 63:434-438; 1991.
10. 10. Haffty, B. G.; Fischer, D.; Rose, M.; Beinneld, M.; McKhann, C. Prognostic factors for local recurrence in the conservatively treated breast cancer patient: A cautious interpretation of the data. J. Clin. Oncol. 9:997-1003; 1991.
11. 11. Haffty, B. G.; Reiss, M.; Beinneld, M.; Fischer, D.; Ward, C.; McKhann, C. Ipsilateral breast tumor recurrence as a predictor of distant disease: Implications for systemic therapy at the time of local relapse. J. Clin. Oncol. 14:52-57; 1996.
12. 12. Haffty, B. G.; Carter, D.; Flynn, S. D.; Fischer, D. B.; Brash, D. E.; Simons, J.; Ziegler, A. M.; Fischer, J. J. Local recurrence vs. new primary: Clinical analysis of 82 breast relapses and potential applications for genetic fingerprinting. Int. J. Radiat. Oncol. Biol. Phys. 27:575-583; 1993.
13. 13. Holland, R.; Connolly, J.; Gelman, R.; Mravunac, M.; Hendriks, J. H.; Verbeek, A. L.; Schnitt, S.; Silver, B.; Boyages, J.; Harris, J. The presence of an extensive intraductal component (EIC) following a limited excision correlates with prominent residual disease in the remainder of the breast. J. Clin. Oncol. 8:113-118; 1990.
14. 14. Jacquemier, J.; Kurtz, J.; Amalric, R.; Brandone, H.; Ayme, Y.; Spitalier, J.-M. An assessment of extensive intraductal component as a risk factor for local recurrence after breast-conserving therapy. Br. J. Cancer 61:873-876; 1990.
15. 15. Kurtz, J. M.; Jacquemier, J.; Amalric, R.; Brandone, H.; Ayme, Y.; Hans, D.; Bressac, C.; Spitalier, J.-M. Why are local recurrences after breast-conserving therapy more frequent in younger patients? J. Clin. Oncol. 8:591-598; 1990.
16. 16. Mate, T. P.; Carter, D.; Fischer, D. B.; Hartman, P. V.; McKhann, C.; Merino, M.; Prosnitz, L. R.; Weissberg, J. B. A clinical and histopathological analysis of the results of conservation surgery and radiation therapy in stage I and II breast carcinoma. Cancer 58:1995-2002; 1986.
17. 17. Nordenskjold, B.; Stal, O.; Skoog, L.; Rutqvist, L.-E.; Carstensen, J.; Wingren, S.; Sullivan, S.; Dufmats, M. S-phase fraction and c-erbb-2 expression related to the survival benefit from adjuvant chemotherapy of breast cancer. Proc. Am. Soc. Clin. Oncol. 13:67; 1994.
18. 18. Paik, S.; Hazan, R.; Fisher, E.; Sass, R.; Fisher, B.; Redmond, C.; Schlessinger, J.; Lippman, M.; King, C. Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: Prognostic significance of erb B-2 protein overexpression in primary breast cancer, J. Clin. Oncol. 8:103-112; 1990.
19. 19. Patterson, M.; Dietrich, K.; Danyluk, J.; Paterson, A.; Lees, A.; Jamil, N.; Hanson, J.; Jenkins, H.; Krause, B.; McBlain, W.; Slamon, D.; Fourney, R. Correlation between c-erb B-2 amplification and risk of recurrent disease in node-negative breast cancer. Cancer Res. 51:556-567; 1991.
20. 20. Pierce, L. J.; Merino, M. J.; D'Angelo, T.; Barker, E. A.; Gilbert, L.; Cowan, K. H.; Steinberg, S. M.; Glatstein, E. Is c-erb B-2 a predictor for recurrent disease in early stage breast cancer? Int. J. Radiat. Oncol. Biol. Phys. 28:395-403; 1994.
21. 21. Rose, M. A.; Henderson, I. C.; Gelman, R.; Boyages, J.; Gore, S. M.; Come, S.; Silver, B.; Recht, A.; Connolly, J. L.; Schnitt, S. J.; Coleman, C. N.; Harris, J. R. Premenopausal breast cancer patients treated with conservative surgery, radiotherapy and adjuvant chemotherapy have a low risk of local failure. Int. J. Radiat. Oncol. Biol. Phys. 17:711-717; 1989.
22. 22. Schnitt, S.; Abner, A.; Gelman, R.; Connolly, J. L.; Recht, R.; Duda, R.; Eberlein, T.; Mayzel, K.; Silver, B.; Harris, J. The relationship between microscopic margins of resection and the risk of local recurrence in breast cancer patients treated with conservative surgery and radiation therapy. Cancer 74:1746-1751; 1994.
23. 23. Schnitt, S. J.; Connolly, J. L.; Harris, J. R.; Hellman, S.; Cohen, R. B. Pathologic predictors of early local recurrence in stage I and II breast cancer treated by primary radiation therapy. Cancer 53:1049-1057; 1984.
24. 24. Slamon, D.; Clark, G.; Wong, S.; Levin, W.; Ullrich, A.; McGuire, W. Human breast cancer: Correlation of relapse and survival with amplification of the Her-2/neu oncogene. Science 235:177-182; 1987.
25. 25. Veronesi, U.; Marubini, E.; Del Vecchio, M.; Manzari, A.; Andreola, S.; Greco, M.; Luini, A.; Merson, M.; Saccozzi, F.; Rilke, F.; Salvadori, B. Local recurrences and distant metastases after conservative breast cancer treatments: Partly independent events. J. Natl. Cancer Inst. 87:19-27; 1995.